Clavis Pharma logo
  • Company
  • Technology
  • Products under development
  • Licensing and Partners
  • Investors
  • News & Events
    • 2010 Press releases
    • 2009 Press releases
    • 2008 Press releases
    • 2007 Press releases
    • 2006 Press releases
    • 2005 Press releases and earlier years
    • News
    • Subscribe
  • Contact us


Search

Subscribe to our newsletter


Terms/Glossary


News & Events
Skriv ut

News Archive


Displaying 1 - 10 of 92 articles


  • |«
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next »
  • »|



25 August 2010
Clavis Pharma - Second Quarter and First Half Report 2010


18 August 2010
Invitation to presentation of Clavis Pharma's second quarter results 2010


18 August 2010
Clavis Pharma recruits first patient in pivotal Phase III study of elacytarabine in late-stage acute myeloid leukaemia


6 August 2010
Clavis Pharma Announces Recruitment of the First Patients in Phase II Study comparing CP-4126 with gemcitabine in pancreatic cancer


24 June 2010
Clavis Pharma announces the appointment of Athos Gianella-Borradori, MD


14 June 2010
Clavis Pharma announces the death of its Chief Medical Officer, Bo I. Nilsson


7 June 2010
Clavis Pharma to present at Jefferies’ Global Life Sciences Conference in New York


26 May 2010
Clavis Pharma ASA to host Capital Markets Day


20 May 2010
Clavis Pharma appoints two internationally experienced pharma executives


4 May 2010
Clavis Pharma ASA to host Capital Markets Day on 16 June


  • |«
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next »
  • »|
Head Office: Parkveien 53 B, NO-0256 Oslo, Norway Tel: +47 24110950 Fax: +47 24110951 Disclaimer